Quick Answer
Arcturus Therapeutics Holdings Inc. reported Operating Income of -$76.26 million for fiscal year 2025.
Arcturus Therapeutics Holdings Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$76.26M | +20.3% |
| 2024 | -$95.67M | -22.3% |
| 2023 | -$78.20M | -742.2% |
| 2022 | $12.18M | +106.0% |
| 2021 | -$202.85M | -183.6% |
| 2020 | -$71.52M | -180.3% |
| 2019 | -$25.51M | -17.0% |
| 2018 | -$21.81M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$16.51M | -53.8% | -42.1% |
| June 30, 2025 | -$11.62M | +45.0% | +31.0% |
| March 31, 2025 | -$16.83M | +44.7% | -56.7% |
| September 30, 2024 | -$10.74M | +44.4% | +49.2% |
| June 30, 2024 | -$21.13M | +61.8% | +30.5% |
| March 31, 2024 | -$30.41M | -306.1% | -57.5% |
| September 30, 2023 | -$19.31M | +47.5% | +65.1% |
| June 30, 2023 | -$55.37M | -150.7% | -475.3% |
- Arcturus Therapeutics Holdings Inc. showed an increase of +20.3% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, Arcturus Therapeutics Holdings Inc.’s operating income has declined by 249.6% (from -$21.81 million to -$76.26 million).
- The most recent figure is from Arcturus Therapeutics Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: